HomeAI · summaries
Storia in 2 fonti
Philip Morris claims FDA nod to market ZYN nicotine pouch as safer than smoking
The FDA has authorized Philip Morris International's ZYN nicotine pouches for reduced-risk marketing. This marks the first such approval for a nicotine pouch product in the United States. The regulator concluded ZYN could significantly reduce harm compared to cigarette smoking. This decision allows adult nicotine users access to science-based health information. The authorization applies to specific marketing claims and authorized ZYN products.
Confronto fonti
2 prospettive sulla stessa storiaTimeline cronologica
- ·
naftemporiki.gr
Η Philip Morris International ανακοινώνει την έγκριση ισχυρισμού διαφοροποιημένου κινδύνου για 20 προϊόντα ZYN από τον Οργανισμό Τροφίμων…
Ο Οργανισμός Τροφίμων και Φαρμάκων των ΗΠΑ (FDA) ενέκρινε τη χρήση ισχυρισμού διαφοροποιημένου κινδύνου για 20 ποικιλίες pouches (σακουλάκια) νικοτίνης ZYN.
- ·
economictimes.indiatimes.com
Philip Morris claims FDA nod to market ZYN nicotine pouch as safer than smoking
The FDA has authorized Philip Morris International's ZYN nicotine pouches for reduced-risk marketing. This marks the first such approval for a nicotine pouch product in the…